ORGN001 (formerly ALXN1101)

· Origin Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ORGN001 (formerly ALXN1101), covering 2023-10-17 to 2023-10-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP [Phase 2]

See pricing